Nonalcoholic fatty liver disease: one entity, multiple impacts on liver health - PubMed (original) (raw)

Review

Nonalcoholic fatty liver disease: one entity, multiple impacts on liver health

Carmen Fierbinteanu-Braticevici et al. Cell Biol Toxicol. 2017 Feb.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is very prevalent and now considered the most common cause of chronic liver disease. Staging the severity of liver damage is very important because the prognosis of NAFLD is highly variable. The long-term prognosis of patients with NAFLD remains incompletely elucidated. Even though the annual fibrosis progression rate is significantly higher in patients with nonalcoholic hepatitis (NASH), both types of NAFLD (nonalcoholic fatty liver and nonalcoholic steatohepatitis) can lead to fibrosis. The risk for progressive liver damage and poor outcomes is assessed by staging the severity of liver injury and liver fibrosis. Algorithms (scores) that incorporate various standard clinical and laboratory parameters alongside imaging-based approaches that assess liver stiffness are helpful in predicting advanced fibrosis.

Keywords: Disease progression; Fatty liver; Liver cirrhosis; Liver fibrosis; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources